Last week, Agilent Technologies (NYSE:A) experienced a price decline of 3%, a movement that may have been influenced by recent changes within the company's board. The announcement of Heidi Kunz's impending resignation from the board and its committees could have introduced some uncertainty, potentially impacting investor sentiment. Additionally, the broad market impact from President Trump's announcement of new tariffs, which saw significant declines in major indices like the Dow Jones and S&P 500, likely contributed to the decline in Agilent's share price, in line with the general market trend during this turbulent period.

Buy, Hold or Sell Agilent Technologies? View our complete analysis and fair value estimate and you decide.

We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Over the past five years, Agilent Technologies achieved a total shareholder return of 56.44%, signaling a positive growth trajectory. During this period, strategic moves such as the implementation of the Ignite transformation plan were pivotal. This initiative aimed to bolster growth via new pricing strategies, digital enhancements, and cost efficiencies. In tandem, Agilent's collaboration with ABB Robotics to innovate laboratory automation has fortified its market standing, attracting clients seeking advanced lab solutions.

Product developments, notably the launch of the Infinity III series, have also played an essential role, enabling Agilent to retain and grow its customer base through technology upgrades. Additionally, strategic partnerships like the one with Quest Diagnostics for a liquid biopsy NGS test expanded market reach. Meanwhile, effective shareholder return strategies, such as completing a substantial share buyback program totaling US$1.72 billion, have underpinned an enhanced shareholder value stance, fostering confidence among investors.

Learn about Agilent Technologies' historical performance here.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com